Mölnlycke Health Care
Mölnlycke Health Care completes investment programme at Oldham factory; expands production line
Mölnlycke Health Care has completed a £2.2 million (EUR 2.8 million, SEK 25 million) investment programme at its Oldham factory in the United Kingdom. The investment programme, aimed increasing the factory's competitiveness and diversifying its production line, has taken just over 12 months to complete and will lead to a 10% increase in headcount, bringing 25 new job opportunities to Oldham.
With a history in the city dating back to 1952, the factory became part of Mölnlycke Health Care in 2005, as part of the acquisition of Medlock Medical.
Already producing tubular bandages such as Tubifast® and Tubigrip® and skin care products such as Epaderm® Cream and Epaderm® Ointment, the investment is designed to expand the factory’s product portfolio to include wound irrigation sachets, including Unisept® and Tisept®, pharmaceutically-based products used to clean wounds and burns.
Both products are to be sold predominantly in the UK, as well as exported to other markets across Europe and Asia.
Nick Douglas, Mölnlycke Health Care's Factory Manager in Oldham, said:
"An investment of this magnitude is a significant commitment and shows that Oldham will play an important role in Mölnlycke Health Care's future production portfolio.
"We are of course pleased to be creating new job opportunities in Oldham, but as part of this programme we have also invested in training our existing staff in the use of new technologies such as steam sterilization."